FDA approves brain scan for ADHD diagnosis

The agency announced yesterday it cleared the Neuropsychiatric EEG-Based Assessment Aid (NEBA) system to help confirm ADHD in people aged six to 17. 

Doctors can use the device to confirm an ADHD diagnosis or to determine if more testing is necessary.

The device, from Georgia-based NEBA Health, measures the frequency of the theta and beta brain waves.